Stock Watch: Q2 Sales Growth Sparks Diverging Reactions To J&J And Novartis

Execs Play Down Tariff, Pricing Threats But LoE Clouds Loom

 
• By Andy Smith
  
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Stock Watch

More from Scrip